BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 08/26/21

Last year, we were looking at distribution changes due to the COVID pandemic sell-off. CEFs distribute out most of their earnings as distributions, so they pay relatively higher yields. However, relatively higher yields mean that any downturn is likely to cause distribution cuts. ...

NBXG was launched several months ago and now we are starting to get some initial information. The fund seems interesting at this time and could provide for some good exposure; however, perhaps waiting until it gets more of a track record could be the best approach. After trading a...

BST recently completed its rights offering and I added the position back to my portfolio. The portfolio has been shifting a bit in the market capitalization, adding in additional small-cap exposure. BST is worth a buy today. For further details see: BST: Worth A Buy For ...

BST's rights offering has concluded, and was 81% subscribed. Shareholder-friendly formula meant that dilution was minimal, at -1.3% to NAV. The fund has sold off after the rights offering, presenting an attractive entry point. For further details see: BST: Decent Value A...

While the size of the listed CEF universe pales in comparison to open-end mutual funds or ETFs, CEFs offer investors several potential benefits that are often overlooked. CEFs can offer access to high-growth private markets in an investor-friendly structure. Unlike mutual funds an...

A total of 6 funds added this month means it was a more active month of buying than the prior. Two of the funds, however, came as a result of swapping one for another for different opportunities. 4 funds make a new addition to my portfolio (EVG, GLQ, GLV and FFC), though FFC I've ...

For the eighth month in a row, equity CEFs on average posted positive returns, rising 1.34% on a NAV basis for June. While for the fourth month running fixed income CEFs posted plus-side returns (+0.85%). Thirty-two percent of all CEFs traded at a premium to their NAV, with 31% of...

BlackRock Science and Technology Trust II of Beneficial Interest (NYSE:BSTZ) traded today at a new 52-week high of $42.29. So far today approximately 76,000 shares have been exchanged, as compared to an average 30-day volume of 116,000 shares. Based on a current price of $42.01, BlackRoc...

I view BST's rights offering more positively than some other recent ones by other managers. Selling/switching before the ex-rights date wins again. A suggested plan of action for the rights and the sister fund, BSTZ. For further details see: BST: Rights Offering Analysis...

When I get a question on a CEF or am looking at a new CEF, these are the first 5 things I will check. The five places I want to look first are; 1. Investment Policy, 2. Quick Review of Holdings, 3. Discount/Premium, 4. Performance, 5. Distributions. Once these items are checked, I...